France· FR:67712453
MEKTOVI 15 mg, comprimé pelliculé
A medicinal product containing binimétinib, registered in France by PIERRE FABRE MEDICAMENT, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- BINIMÉTINIB
- Manufacturer
- PIERRE FABRE MEDICAMENT
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009301568727 Plaquettes PVC PVDC aluminium de 12 comprimésEUR 2.09
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Binimétinib in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayMektoviPierre Fabre Medicament
- SwitzerlandMektovi 15 mg, FilmtablettenPierre Fabre Pharma SA
- CzechiaMEKTOVIPIERRE FABRE MEDICAMENT, Lavaur
- SpainMEKTOVI 15 MG COMPRIMIDOS RECUBIERTOS CON PELICULAPierre Fabre Medicament
- PolandMektoviPierre Fabre Medicament
- SwedenMektovi 15 mg Filmdragerad tablettPierre Fabre Medicament
- BelgiumMektovi 15 mgPierre Fabre Médicament
- United StatesMEKTOVIArray BioPharma Inc.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Mektovi
- Liechtenstein · Mektovi
- Norway · Mektovi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/50b3efe7-b27a-432b-8f67-fadc9067643f GET /v1/drugs/50b3efe7-b27a-432b-8f67-fadc9067643f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "67712453",
"date_amm": "2018-09-20",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/18/1315",
"substance": "BINIMÉTINIB",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about binimétinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.